Basit öğe kaydını göster

dc.contributor.authorÇOKUĞRAŞ, HALUK CEZMİ
dc.contributor.authorKASAPÇOPUR, ÖZGÜR
dc.contributor.authorOnal, Pinar
dc.contributor.authorApaydin, Gozde
dc.contributor.authorAYGÜN, FATMA DENİZ
dc.contributor.authorArslan, Huseyin
dc.contributor.authorKILIÇ BAŞKAN, AZER
dc.contributor.authorHEPKAYA, EVRİM
dc.contributor.authorMERAL, Özge
dc.contributor.authorBARUT, KENAN
dc.contributor.authorHAŞLAK, FATİH
dc.contributor.authorVAROL, ŞEVKİ ERDEM
dc.contributor.authorGunalp, Aybuke
dc.contributor.authorKAYNAR, Özge
dc.contributor.authorYildiz, Mehmet
dc.contributor.authorAdrovic, Amra
dc.contributor.authorŞAHİN, SEZGİN
dc.contributor.authorKES, GÜLŞEN
dc.contributor.authorAyzit-Kilinc, Ayse
dc.contributor.authorAkdeniz, Beste
dc.date.accessioned2022-07-04T13:54:28Z
dc.date.available2022-07-04T13:54:28Z
dc.date.issued2022
dc.identifier.citationHAŞLAK F., VAROL Ş. E. , Gunalp A., KAYNAR Ö., Yildiz M., Adrovic A., ŞAHİN S., KES G., Ayzit-Kilinc A., Akdeniz B., et al., "Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children", JOURNAL OF CLINICAL MEDICINE, cilt.11, sa.8, 2022
dc.identifier.issn2077-0383
dc.identifier.otherav_5f4baded-b060-4201-be18-8f21bfcacff3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/182970
dc.identifier.urihttps://doi.org/10.3390/jcm11082102
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/5f4baded-b060-4201-be18-8f21bfcacff3/file
dc.description.abstract(1) Background: We aimed to describe the clinical features and outcomes of coronavirus disease-2019 (COVID-19) in children and late adolescents with inflammatory rheumatic diseases (IRD) and to measure their severity risks by comparing them with healthy children. (2) Methods: Among children and late adolescents found to be severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) positive via polymerase chain reaction (PCR) test, IRD patients with an at least six-months follow-up duration, and healthy children were included in the study. Data were obtained retrospectively. (3) Results: A total of 658 (339 (51.5%) females) (healthy children: 506, IRD patients: 152) subjects were included in the study. While 570 of 658 (86.6%) experienced COVID-19-related symptoms, only 21 (3.19%) required hospitalization with a median duration of 5 (1-30) days. Fever, dry cough, and fatigue were the most common symptoms. None of evaluated subjects died, and all recovered without any significant sequelae. The presence of any IRD was found to increase the risk of both hospitalization (OR: 5.205; 95% CI: 2.003-13.524) and symptomatic infection (OR: 2.579; 95% CI: 1.068-6.228). Furthermore, increasing age was significantly associated with symptomatic infection (OR: 1.051; 95% CI: 1.009-1.095). (4) Conclusions: Our study emphasizes that pediatric rheumatologists should monitor their patients closely for relatively poor COVID-19 outcomes.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectFamily Practice
dc.subjectFundamentals and Skills
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectTIP, GENEL & İÇECEK
dc.subjectHealth Sciences
dc.subjectGeneral Medicine
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.titleComparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL MEDICINE
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume11
dc.identifier.issue8
dc.contributor.firstauthorID3416861


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster